Fig. 7From: Exosome-based engineering strategies for the diagnosis and treatment of oral and maxillofacial diseasesT cell exosome–derived miR-142-3p as a pathogenic driver of immunopathology in SS. MiR-142-3p is overexpressed in salivary gland lesions of SS patients [77]Back to article page